TerminatedNCT02893371
Longitudinal Comparative Effectiveness of Bipolarity Therapies
Observational studyUnited States
Understand this study
- Listed locations
- AlbuquerqueSee all locations and recruitment
What to know before participating
A point to clarify
This summary does not cover all risks or eligibility requirements. What risks or changes to my care would apply to me?
Things to check before joining
Study start dateStarted: September 2016
- Recruitment status
- Terminated
- Enrollment listed in the registry
- 1,037,352
- Sponsor
- University of New Mexico
- Sponsor type
- University
- Study type
- Observational
- Intervention type
- Drug
- Locations
- United States
- Age range
- Not clearly listed
- Official registry ID
- NCT02893371
- Official title
Show the full official title
Longitudinal Comparative Effectiveness of Bipolar Disorder Therapies
Recruitment & locations
TerminatedThis badge reflects the study status reported by the registry. Check the registry for the latest information.
Albuquerque
Interested in joining this study?
Questions about this study
Who is behind this study?
The study sponsor is University of New Mexico, a university.
Does this study involve medication?
Yes. The study involves medication, including Lithium Carbonate, lamotrigine, Valproic Acid, Oxcarbazepine, Carbamazepine, Ziprasidone, Risperidone, Quetiapine, Olanzapine, Aripiprazole, Fluoxetine / Olanzapine, Haloperidol, Perphenazine, Clozapine, Asenapine, Lurasidone, Paliperidone, Mirtazapine, Bupropion, Desvenlafaxine, Duloxetine, Venlafaxine, Citalopram, Escitalopram, Fluoxetine, Fluvoxamine, Paroxetine, Sertraline, Vilazodone and Doxepin.
Is this study still recruiting?
The registry lists this study as terminated.
